PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-12-23

Date Title Company
02-Jan-2025 Combination of Poolbeg and HOOKIPA Pharma Inc Poolbeg Pharma plc
02-Jan-2025 HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture HUTCHMED
02-Jan-2025 European Commission approves RYBREVANT®▼ (amivantamab) in combination with LAZCLUZE®▼ (lazertinib) for the first-line treatment of patients with EGFR-mutated advanced non-small cell lung cancer Janssen-Cilag International NV
02-Jan-2025 Ancient DNA unlocks new understanding of migrations in the first millennium AD Francis Crick Institute
02-Jan-2025 XBiotech Pauses Rheumatology program XBiotech
02-Jan-2025 Sanofi initiates phase 3 program for PCV21 and expands collaboration with SK bioscience for next-generation pneumococcal conjugate vaccines Sanofi
23-Dec-2024 Abivax Announces a Change to the Composition of its Board of Directors ABIVAX
23-Dec-2024 Xlife Sciences AG Announces Potential Acquisition of Portfolio Company FUSE-AI GmbH by Pineapple Power Corporation PLC at an Expected Valuation of EUR 80-90 million Xlife Sciences AG
23-Dec-2024 Human Microbiome Market Expected to Reach USD 6.5 Billion By 2032 Global Market Insights, Inc.
23-Dec-2024 Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025 AccessWire
23-Dec-2024 Bench-top Dental Autoclaves Market to Hit USD 201.9 Million by 2032 Global Market Insights, Inc.
23-Dec-2024 Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease Newswire
23-Dec-2024 Hochul Signs Step Therapy Reform Measures Into Law AccessWire
23-Dec-2024 China's Digital Healthcare Transformation: Local Vendors Lead 2025 EHR Adoption, Highlights Black Book Research AccessWire
23-Dec-2024 Open Healthcare Inc. Expands U.S. Operations With CTON Laboratory Acquisition, New Facility in Gardena, and Appointment of New COO AccessWire
23-Dec-2024 Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000 AccessWire
23-Dec-2024 Honeycomb Clinic Positions for Public Offering AccessWire
23-Dec-2024 Ensysce Biosciences Regains Full Compliance with Nasdaq AccessWire
23-Dec-2024 Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease AccessWire
23-Dec-2024 NanoViricides is in a Great Position to Fight Potential Bird Flu Pandemic with a Drug that the Mercurial H5N1 Influenza A Virus is Unlikely to Escape AccessWire